93 related articles for article (PubMed ID: 27580959)
41. Jakking up tumor registry reporting of the myeloproliferative neoplasms.
Selinger HA; Ma X
Am J Hematol; 2009 Feb; 84(2):124-6. PubMed ID: 19117021
[No Abstract] [Full Text] [Related]
42. Myeloproliferative disease in patients with a history of multiple blood donations: a report of 8 cases.
Randi ML; Rossi C; Barbone E; Cavatton G; Fabris F; Girolami A
Haematologica; 1994; 79(2):137-40. PubMed ID: 8063260
[TBL] [Abstract][Full Text] [Related]
43. Post-Transplant Lymphoproliferative Disorder in Kidney Transplant Recipients: A Single-Center Experience in Japan.
Ishihara H; Shimizu T; Unagami K; Hirai T; Toki D; Omoto K; Okumi M; Imai Y; Ishida H; Tanabe K
Ther Apher Dial; 2016 Apr; 20(2):165-73. PubMed ID: 26948427
[TBL] [Abstract][Full Text] [Related]
44. Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? An age-period-cohort analysis on Norwegian data from 1953 to 1997.
Thu GO; Hem LY; Hansen S; Møller B; Norstein J; Nøkleby H; Grotmol T
Int J Cancer; 2006 Apr; 118(8):2035-9. PubMed ID: 16287082
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of hepatitis C virus in lymphoproliferative disorders.
Bilwani F; Zaidi Y; Kakepoto GN; Adil SN; Khurshid M
J Pak Med Assoc; 2004 Apr; 54(4):202-6. PubMed ID: 15241999
[TBL] [Abstract][Full Text] [Related]
46. Lymphoproliferative and Subsequent Myeloproliferative Disorder - A One Way Street?
Subedi P; Kate Y; Syed MP; Siddiqui AD
Balkan Med J; 2021 May; 38(3):201-202. PubMed ID: 34142965
[No Abstract] [Full Text] [Related]
47. Familial occurrence of chronic lymphocytic leukaemia in Norway.
Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
[TBL] [Abstract][Full Text] [Related]
48. Sentinel lymph node surgery for staging of breast carcinoma in patients with lymphoproliferative disease.
Dy BM; Reynolds CA; Wahner-Roedler DL; Boughey JC
Am Surg; 2010 Dec; 76(12):1423-5. PubMed ID: 21265361
[TBL] [Abstract][Full Text] [Related]
49. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
Loni C; Ricci S; Azzarà A; Bertoncini G
Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
[TBL] [Abstract][Full Text] [Related]
50. Tumours in kidney-transplanted patients: a comprehensive one-centre study.
Alamartine E; Berthoux F
Transplant Proc; 1995 Apr; 27(2):1761-3. PubMed ID: 7725491
[No Abstract] [Full Text] [Related]
51. Coexistence of sarcoidosis and malignant disease: causality or coincidence?
Brincker H
Sarcoidosis; 1989 Mar; 6(1):31-43. PubMed ID: 2657921
[TBL] [Abstract][Full Text] [Related]
52. Cancer cytogenetics.
Sanger WG; Armitage JO; Purtilo DT
Nebr Med J; 1984 Oct; 69(10):335-7. PubMed ID: 6493390
[No Abstract] [Full Text] [Related]
53. Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations.
Dubois A; Dauzat M; Pignodel C; Pomier-Layrargues G; Marty-Double C; Lopez FM; Janbon C
Hepatology; 1993 Feb; 17(2):246-50. PubMed ID: 8428721
[TBL] [Abstract][Full Text] [Related]
54. Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.
Roaldsnes C; Holst R; Frederiksen H; Ghanima W
Eur J Haematol; 2017 Jan; 98(1):85-93. PubMed ID: 27500783
[TBL] [Abstract][Full Text] [Related]
55. [Determination of plasma fibronectin in myeloproliferative and lymphoproliferative diseases and other malignancies].
Kalabay L; Cseh K; Jakab L; Török J; Pozsonyi T; Marticsek J; Benedek S
Immun Infekt; 1986 Feb; 14(1):13-7. PubMed ID: 3082743
[TBL] [Abstract][Full Text] [Related]
56. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.
Sørensen AL; Hasselbalch HC
Leuk Res; 2016 Feb; 41():27-35. PubMed ID: 26718091
[TBL] [Abstract][Full Text] [Related]
57. Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014.
Baade PD; Ross DM; Anderson LA; Forsyth C; Fritschi L
Am J Hematol; 2019 Apr; 94(4):E107-E109. PubMed ID: 30663086
[No Abstract] [Full Text] [Related]
58. A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms.
Sakata-Yanagimoto M; Yokoyama Y; Muto H; Obara N; Kurita N; Kato T; Hasegawa Y; Miyazaki Y; Kurokawa M; Chiba S
Ann Hematol; 2016 Apr; 95(5):829-30. PubMed ID: 26891876
[No Abstract] [Full Text] [Related]
59. Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseases.
Bach AG; Behrmann C; Holzhausen HJ; Katzer M; Arnold D; Spielmann RP; Surov A
Acta Radiol; 2012 Apr; 53(3):343-8. PubMed ID: 22287149
[TBL] [Abstract][Full Text] [Related]
60. Lymphoproliferative disorders in four orthotopic liver transplant patients.
Minello-Franza A; Berjamy F; Bresson-Hadni S; Angonin R; Becker MC; Mantion G; Miguet JP
Transplant Proc; 1995 Apr; 27(2):1770-3. PubMed ID: 7725496
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
